Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension
Clinical trial NCT00926289 · COMPLETED
Trial details
- NCT number
- NCT00926289
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-04-01
- Enrollment
- 894
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.